• About
• Links
• Contact
• Sitemap

Animal Health Products Antibacterials Markets

Veterinary antibacterials comprise some of the most important pharmaceutical products on the animal health market. Yet despite a difficult regulatory environment--driven by concerns over the development of antibacterial resistance in consumers of livestock products--new products are still being launched. This has resulted in significant changes in the animal health products market. This study offers a detailed examination of the shape of the animal health products market globally over the next several years specific to antibacterials, analyzing both the livestock and companion animal markets.

Table of Contents

• 1Report Overview4
  • 1.1Objectives of Report4
  • 1.2Scope of Report4
  • 1.3Methodology4
  • 1.4Executive Summary5
  
  
• 2Animal Health Products Antibacterial Markets6
  • 2.1Overview of Animal Health Products Market6
    • 2.1.1World Products Market7
    • 2.1.2U.S. Animal Health Products Market8
    • 2.1.3European Animal Health Products Markets9
    • 2.1.4Asian Animal Health Products Markets10
  • 2.2Key Sector Highlights11
  • 2.3Biologics Products Category12
  • 2.4Companion Animal Health Products12
  
  
• 3Common Animal Diseases13
  • 3.1Swine Fevers (African, Classical - Hog Cholera)16
  • 3.2Yellow Fever16
  • 3.3Anthrax16
  • 3.4Crimean-Congo Hemorrhagic Fever16
  • 3.5Foot and Mouth Disease (FMD)17
  • 3.6Bovine Anaplasmosis17
  • 3.7Bovine Babesiosis18
  • 3.8Bovine Brucellosis19
  • 3.9Bovine Genital Campylobacteriosis19
  • 3.10Bovine Tuberculosis19
  • 3.11Bovine Cysticercosis19
  • 3.12Bovine Spongiform Encephalopathy20
  • 3.13Dermatophilosis21
  • 3.14Enzootic Bovine Leukosis21
  • 3.15Hemorrhagic Septicemia21
  • 3.16Infectious Bovine Rhinotracheitis / Infectious Pustular Vulvovaginitis21
  • 3.17Theileriosis22
  • 3.18Trichomonosis22
  • 3.19Vesicular Stomatitis22
  • 3.20Swine Vesicular Disease  Picornaviridae Enterovirus23
  • 3.21Rinderpest23
  • 3.22Peste Des Petits Ruminants23
  • 3.23Contagious Bovine Pleuropneumonia23
  • 3.24Lumpy Skin Disease24
  • 3.25Rift Valley Fever24
  • 3.26Bluetongue  Reoviridae Orbivirus24
  • 3.27Ovine Epididymitis (Brucella Ovis)25
  • 3.28Caprine and Ovine Brucellosis (Excluding B. Ovis)25
  • 3.29Caprine Arthritis/Encephalitis25
  • 3.30Contagious Agalactia25
  • 3.31Contagious Caprine Pleuropneumonia26
  • 3.32Enzootic Abortion of Ewes (Ovine Chlamydiosis)26
  • 3.33Avian Chlamydiosis26
  • 3.34Pullorum Disease27
  • 3.35Myxomatosis27
  • 3.36Tularemia27
  • 3.37Contagious Equine Metritis28
  • 3.38Dourine28
  • 3.39Epizootic Lymphangitis28
  • 3.40Porcine Brucellosis28
  • 3.41Commercially-Significant Bacterial Infections in Farm Animals29
  
  
• 4Anti-bacterials Markets31
  • 4.1 Overview31
  • 4.2Antibiotics Market Size32
  • 4.3 Global Sales of Animal Health Antibiotics by Region32
    • 4.3.1U.S. Sales of Animal Health Antibiotics32
    • 4.3.2European Sales of Animal Health Antibiotics36
    • 4.3.3Japanese Sales of Animal Health Antibiotics37
  • 4.4Animal Health Antibiotics Market Drivers37
  • 4.5Growth Promotion in Livestock38
  
  
• 5Regulatory Overview of the Veterinary Health Market42
  • 5.1Regulatory Environment42
  • 5.2General Overview42
  • 5.3Product Marketing Authority43
  • 5.4Regulation of Animal Health Products in the European Union43
  • 5.5Regulation of Animal Health Products in the U.S.45
    • 5.5.1USDA45
    • 5.5.2FDA45
    • 5.5.3EPA46
  • 5.6Regulation of Animal Health Products in Japan46
    • 5.6.1Japanese Regulatory Environment46
    • 5.6.2Withdrawal Periods46
    • 5.6.3Japanese Filing Procedures for New Animal Drug Applications46
    • 5.6.4Use of Outdated Animal Studies46
    • 5.6.5Brand-Specific Listing for Antimicrobial, Antibiotic and Other Feed Additives47
  • 5.7Proposed Regulation of Animal Antibiotics47
  • 5.8Antibiotic Acquired Resistance and Animal Usage47
  
  
• 6Business Trends in the Industry49
  • 6.1European Animal Health Industry49
  • 6.2Trends Driving Demand49
  • 6.3Antibiotic Usage49
  • 6.4Mergers and Acquisitions49
  • 6.5Bioterrorism and Food-borne PathogensWHO Guidelines50
  • 6.6Animal Health Additive Growth Trends50
  
  
• 7Company Profiles52
  • 7.1Abbott Laboratories52
  • 7.2Agricultural Research Service52
  • 7.3Alpharma, Inc.53
  • 7.4BASF Agricultural Products and Nutrition55
  • 7.5Bayer Animal Health56
  • 7.6Boehringer Ingelheim Corp.56
  • 7.7Elanco Animal Health57
  • 7.8Fort Dodge Animal Health (Wyeth)57
  • 7.9Heska Animal Health58
  • 7.10Intervet International60
  • 7.11IVAX Corporation60
  • 7.12Merial Animal Health60
  • 7.13Novartis Animal Health61
  • 7.14Pfizer Animal Health62
  • 7.15Roche Animal Nutrition and Health65
  • 7.16Sanofi-Aventis66
  • 7.17Schering-Plough Animal Health67
  • 7.18Virbac S.A.68
  • 7.19Wyeth (Fort Dodge Animal Health)68
  
  
  

 

INDEX OF FIGURES

Figure 2.1: Worldwide Animal Health Products Market by Region, 20068

Figure 2.2: U.S. Companion Animal Healthcare Products Share of Overall Animal Health Product Sales, 20069

Figure 2.3: Worldwide Animal Health Products Market by Species, 200611

INDEX OF TABLES

Table 2.1: World Market for Animal Health Products, 2004-20127

Table 2.2: Global Sales of Animal Health and Nutrition Products, 2004-20127

Table 2.3: Worldwide Animal Health Products Market by Region, 20068

Table 2.4: U.S. Animal Health Product Sales, 2004-20129

Table 2.5: Japanese Animal Health Market, 2000-201210

Table 2.6: Worldwide Animal Health Product Sales for Leading Producers, 200610

Table 2.7: Dog and Cat Food Manufacturers12

Table 3.1: Diseases13

Table 3.2: Multiple Species Diseases13

Table 3.3: Cattle Diseases14

Table 3.4: Sheep and Goat Diseases14

Table 3.5: Equine Diseases14

Table 3.6: Swine Diseases15

Table 3.7: Avian Diseases15

Table 3.8: Fish Diseases15

Table 3.9: Other Veterinary Diseases16

Table 3.10: Use Categories for Anti-bacterials in Animal Health29

Table 3.11: Commercially-Significant Bacterial Infections in Pigs29

Table 3.12: Commercially-Significant Bacterial Infections in Poultry30

Table 3.13: Commercially-Significant Bacterial Infections in Cattle30

Table 4.1: Leading Antimicrobials by Type for Animal Health31

Table 4.2: Antibiotics Used in Animal Health by Family32

Table 4.3: Worldwide Sales of Animal Health Antibiotics, 2004-201232

Table 4.4: U.S. Sales of Animal Health Antibiotics, 2004-201233

Table 4.5: U.S. Volume of Animal Health Antibiotics Used, 1999-200633

Table 4.6: Sales of Bayer\'s Baytril®, 2003-200934

Table 4.7: Enrofloxacin (Quinolones)34

Table 4.8: Antibiotic Susceptibility for Common Swine Pathogens vs. Excenel®35

Table 4.9: U.S. Volume of Animal Health Antibiotics Used by Class Category, 2000-200535

Table 4.10: European Sales of Animal Health Antibiotics, 2004-201236

Table 4.11: European Veterinary Consumption of Therapeutic Antibiotics36

Table 4.12: Japanese Sales of Animal Health Antibiotics, 2004-201237

Table 4.13: Animal Health Antibiotics Market Drivers37

Table 4.14: Commercial Animal Health Anti-bacterials by Class Type40

Table 4.15: Bacterial and Protozoal Threats to Poultry41

Table 4.16: Bacterial and Protozoal Threats to Pigs41

Table 7.1: Pfizer Animal Health Products63

Table 7.2: Pfizer Livestock Products65

Table 7.3: Pfizer Equine Products65

Table 7.4: Pfizer Companion Animal Products65

 

Download Table of Contents as a PDF

Other users found this report page using the following search terms: animal health veterinary animal health products pfizer market sales segmentation antibiotics markets companion

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.